Addressing Anxiety in 2-3-Year-Olds: A Pilot Intervention Study
Addressing Anxiety in 2-Year-Olds: A Pilot Screening and Intervention Study
1 other identifier
interventional
90
1 country
1
Brief Summary
The purpose of this study is to test the feasibility and efficacy of intervening with 2-year-old children with elevated temperamental Fear and/or Shyness or 3-year-old children with elevated anxiety and their parents, using a parent-child Cognitive Behavioral Therapy (CBT) protocol to reduce anxiety disorders and maintain reduced anxiety at one-year follow-up. Before the COVID-19 pandemic, study visits and treatment sessions were conducted in office. Now all visits and treatment sessions are conducted remotely.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2019
CompletedFirst Posted
Study publicly available on registry
July 31, 2019
CompletedStudy Start
First participant enrolled
September 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedJanuary 15, 2026
January 1, 2026
5.9 years
July 29, 2019
January 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Response Rate (proportion of participants rated as 1 or 2 on Clinical Global Impression of Anxiety-Improvement Measure (CGI-I)
The CGI-I is a 7-point scale from 1 (Very Much Improved) to 7 (Very Much Worse). It will be rated by a clinician interviewer blind to treatment condition
Baseline to four-month follow-up
CGI-Severity Ratings
Compared between groups at 4- and 8-month FU
Study Arms (3)
Active Treatment
EXPERIMENTALUp to 12 sessions of Parent-Child CBT using an adaptation of the Being Brave protocol
Parent Education
ACTIVE COMPARATORParents receive educational materials about how to help young children overcome shyness and anxiety
Monitoring
NO INTERVENTIONInterventions
Parents receive educational materials about helping children overcome shyness and fear
Eligibility Criteria
You may qualify if:
- The child scores \>1 Standard Deviation (SD) above reported means for the Fear or Shyness scales on the Early Childhood Behavior Questionnaire (ECBQ) (if child is 21-35 months) or the child scores \>1SD above reported means for the Total Anxiety, Generalized Anxiety, Social Anxiety, Physical Injury Fears, or Separation Anxiety scales on the Preschool Anxiety Scale (PAS) (if child is 36-47 months) as completed by a parent
- The parents are able to speak, understand, and read English
- The child must have a working knowledge of English.
You may not qualify if:
- Autism Spectrum Disorder (ASD) or global developmental delay in the child
- The child has disruptive behavior so severe as to interfere with participation in intervention sessions
- The child has a different primary disorder for which CBT for anxiety is inappropriate (e.g. severe depression, depression in the mother, significant medical disorder).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dina Hirshfeld-Becker, PhD
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-Director, MGH Child CBT Program
Study Record Dates
First Submitted
July 29, 2019
First Posted
July 31, 2019
Study Start
September 27, 2019
Primary Completion
September 1, 2025
Study Completion (Estimated)
June 1, 2026
Last Updated
January 15, 2026
Record last verified: 2026-01